Creative Medical Technology Holdings, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Creative Medical Technology Holdings, Inc. (CELZ) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 7 shares for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2023-03-31
- Creative Medical Technology Holdings, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 7.00 shares, a 0.00% change from fiscal 2021.
- Creative Medical Technology Holdings, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2021 was 7.00 shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|
| 2022-12-31 | 7.00 shares 10-K · filed 2023-03-31 |
| 2021-12-31 | 7.00 shares 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |